WO2015024992A3 - Treatment of asthma - Google Patents

Treatment of asthma Download PDF

Info

Publication number
WO2015024992A3
WO2015024992A3 PCT/EP2014/067812 EP2014067812W WO2015024992A3 WO 2015024992 A3 WO2015024992 A3 WO 2015024992A3 EP 2014067812 W EP2014067812 W EP 2014067812W WO 2015024992 A3 WO2015024992 A3 WO 2015024992A3
Authority
WO
WIPO (PCT)
Prior art keywords
asthma
treatment
compositions
methods
application
Prior art date
Application number
PCT/EP2014/067812
Other languages
French (fr)
Other versions
WO2015024992A2 (en
Inventor
Christian Itin
Cheryl LASSEN
Philippe Saudan
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of WO2015024992A2 publication Critical patent/WO2015024992A2/en
Publication of WO2015024992A3 publication Critical patent/WO2015024992A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/711Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Abstract

The application is related to compositions and methods for the treatment of asthma.
PCT/EP2014/067812 2013-08-22 2014-08-21 Treatment of asthma WO2015024992A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13181411.3 2013-08-22
EP13181411 2013-08-22

Publications (2)

Publication Number Publication Date
WO2015024992A2 WO2015024992A2 (en) 2015-02-26
WO2015024992A3 true WO2015024992A3 (en) 2015-04-30

Family

ID=49028958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/067812 WO2015024992A2 (en) 2013-08-22 2014-08-21 Treatment of asthma

Country Status (1)

Country Link
WO (1) WO2015024992A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024481A2 (en) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
US20030087848A1 (en) * 2000-02-03 2003-05-08 Bratzler Robert L. Immunostimulatory nucleic acids for the treatment of asthma and allergy
WO2004000351A1 (en) * 2002-06-20 2003-12-31 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
WO2005042018A2 (en) * 2003-10-30 2005-05-12 Coley Pharmaceutical Gmbh C-class oligonucleotide analogs with enhanced immunostimulatory potency
WO2007068747A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007144150A1 (en) * 2006-06-12 2007-12-21 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087848A1 (en) * 2000-02-03 2003-05-08 Bratzler Robert L. Immunostimulatory nucleic acids for the treatment of asthma and allergy
WO2003024481A2 (en) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
WO2004000351A1 (en) * 2002-06-20 2003-12-31 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
WO2005042018A2 (en) * 2003-10-30 2005-05-12 Coley Pharmaceutical Gmbh C-class oligonucleotide analogs with enhanced immunostimulatory potency
WO2007068747A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007144150A1 (en) * 2006-06-12 2007-12-21 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BEEH KAI-MICHAEL ET AL: "The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma.", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 131, no. 3, March 2013 (2013-03-01), pages 866 - 874, XP002714508, ISSN: 1097-6825 *
KATO GO ET AL: "Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.", BIOMARKER INSIGHTS, vol. 8, 4 August 2013 (2013-08-04), pages 97 - 105, XP002714510, ISSN: 1177-2719 *
KNORR B ET AL: "Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.", PEDIATRICS, vol. 108, no. 3, September 2001 (2001-09-01), pages E48, XP002714509, ISSN: 1098-4275 *
MASSANARI M ET AL: "Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.", RESPIRATORY MEDICINE, vol. 104, no. 2, February 2010 (2010-02-01), pages 188 - 196, XP002714507, ISSN: 1532-3064 *
PAVORD IAN D ET AL: "Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.", vol. 380, part 9842 18 August 2012, LANCET, ISSN: 1474-547X, pages: 651 - 659, XP002714506 *

Also Published As

Publication number Publication date
WO2015024992A2 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
EP3030266A4 (en) Topical compositions and methods of using the same
EP2988781A4 (en) Compositions and methods for the therapy and diagnosis of influenza
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
WO2015085318A3 (en) Targeted adaptive vaccines
EP3060041A4 (en) Prostacyclin compounds, compositions and methods of use thereof
EP3089989A4 (en) Cas9 crystals and methods of use thereof
EP3082819A4 (en) Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
EP2961382A4 (en) Topical compositions and methods of using the same
WO2015066452A3 (en) Methods of treating pediatric cancers
HK1214171A1 (en) Cenicriviroc compositions and methods of making and using the same
EP2991946A4 (en) Pumice-containing remedial compositions and methods of use
EP3060611A4 (en) Aqueous coating composition and process of making the same
EP2991658A4 (en) Antimicrobial compositions and methods of making the same
EP2967049A4 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
HK1217896A1 (en) Compositions and methods for the treatment of pervasive development disorders
IL239893A0 (en) Compositions comprising 15-ohepa and methods of using the same
EP3068500A4 (en) Fertilizer compositions and methods of making and using the same
EP3004396A4 (en) Methods and compositions for the treatment of cancer
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EP3052078A4 (en) Methods and compositions for improving the appearance of skin
EP3039022A4 (en) Compositions and methods for the treatment of metabolic and body weight related disorders
WO2015092810A3 (en) Amorphous form of idelalisib
HK1220374A1 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3082427A4 (en) Compositions and methods for treatment of glaucoma
EP2958591A4 (en) Methods and compositions relating to the treatment of cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14757887

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14757887

Country of ref document: EP

Kind code of ref document: A2